Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 558-569

  Fang, H J ^a   Yang, J K ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme 2; Glucose homeostasis; mRNA expression; Pancreas; Protein expression; Rat model

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; GLUCAGON; INSULIN; MESSENGER RNA; PANCREAS POLYPEPTIDE; RENIN; SOMATOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GLYCEMIC CONTROL; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY GRANULE; TISSUE SPECIFICITY;

EID: 77953723083     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800218     Document Type: Article

References (27)

1. Peach M: Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 1977; 57: 313-370.
2. Vickers C, Hales P, Kaushik V, et al Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol; Chem 2002; 277: 14838-14843.
3. Danilczyk U, Penninger JM: Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006; 98: 463-471.
4. Crackower MA, Sarao R, Oudit GY, et al Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-828.
5. Goulter AB, Goddard MJ, Allen JC, et al ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2004; 2: 19.
6. Yamazato M, Yamazato Y, Sun C, et al Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 2007; 49: 926-931.
7. Oudit GY, Herzenberg AM, Kassiri Z, et al Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006; 168: 1808-1820.
8. Reich HN, Oudit GY, Penninger JM, et al Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 2008; 74: 1610-1616.
9. Niu MI, Yang IK, Lin SS, et al Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008; 34: 56-61.
10. Donoghue M, Hsieh F, Baronas E, et al A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: El-E9.
11. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2002; 275: 33238-33243.
12. Harmer D, Gilbert M, Borman R, et al Quantitative mRNA expression profiling of ACE2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002; 532: 107-110.
13. Li W, Moore MJ, Vasilieva N, et al Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-454.
14. Burrell LM, Risvanis J, Kubota E, et al Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005; 26: 369-375.
15. Yamazato Y, Ferreira AJ, Hong KH, et al: Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer. Hypertension 2009; 54: 365-371.
16. Epelman S, Shrestha K, Troughton RW, et al. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail 2009; 15: 565-571.
17. Mizuiri S, Hemmi H, Arita M, et al: Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 2008; 51: 613-623.
18. Lovren F, Pan Y, Quan A, et al: Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol J Hearf Circ Physiol 2008; 295: HI377-H1384.
19. Tikellis C, Bialkowski K, Pete I, et al ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabefes 2008; 57: 1018-1025.
20. Carlsson PO: The renin-angiotensin system in the endocrine pancreas. JOP 2001; 2: 26-32.
21. Leung PS: Pancreatic renin-angiotensin system: a novel target for the potential treatment of pancreatic diseases? JOP 2003; 4: 89-91.
22. Perkins BA, Aiello LP, Krolewski AS: Diabetes complications and the renin-angiotensin system. N Engl J Med 2009; 361: 83-85.
23. Estacio RO: Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors. Postgrad Med 2009; 121: 33-44.
24. Abuissa H, lones PG, Marso SP, et al Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005; 46: 821-826.
25. Lin Q, Keller RS, Weaver B, et al Interaction of ACE2 and integrin pi in failing human heart. Biochim BiophysActa 2004; 1689: 175-178.
26. Ding Y, He L, Zhang Q, et al: Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203: 622-630.
27. Yang JK, Lin SS, Ji XJ, et al Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2009; e-pub ahead of print.